Ultraviolet irradiation induces cyclooxygenase-2 expression in keratinocytes

British Journal of Dermatology

Volumn 140, Issue 6, 1999, Pages 1017-1022

  Isoherranen, K ^a,c   Punnonen, K ^b   Jansen, C ^a   Uotilas, P ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cyclooxygenase 1; Cyclooxygenase 2; HaCaT keratinocytes; Human skin; Protein kinase C; Reactive oxygen intermediates; Ultraviolet radiation

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ACETYLCYSTEINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GENISTEIN; HYDROGEN PEROXIDE; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLAR RADIATION; ULTRAVIOLET B RADIATION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ACETYLCYSTEINE; ADULT; ANTIOXIDANTS; BLOTTING, NORTHERN; CELL LINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENZYME INHIBITORS; EPIDERMIS; GENE EXPRESSION; GENISTEIN; HUMANS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; ISOENZYMES; KERATINOCYTES; MALE; MEMBRANE PROTEINS; OXIDANTS; PHOSPHOPROTEIN PHOSPHATASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; RNA, MESSENGER; ULTRAVIOLET RAYS; VANADATES;

EID: 0032983592     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02897.x     Document Type: Article

References (35)

1. 1 Greaves MW, Sondergaard J. Pharmacological agents released in ultraviolet inflammation studied by continuous skin perfusion. J Invest Dermatol 1970; 54: 365-7.
2. 2 Hawk JLM, Parrish JA. Responses of normal skin lo ultraviolet irradiation In: The Science of Photomedicine (Regan JD, Parrish JA, eds). New York: Plenum Press, 1982: 219-60.
3. 5 Hruza L, Pentland AP. Mechanisms of UV-induced inflammation. J Invest Dermatol 1993; 100: 35-418.
4. 4 Punnonen K, Puustinen T, Jansen CT. The effect of the anti-psoriatic drug metabolite etretin (Ro 10-1670) on UVB irradiation induced changes in the metabolism of arachidonic acid in human keratinocytes in culture. Photochem Photobiol 1986; 44: 44: 623-7.
5. 2 in human skin. Am J Physiol 1996; 270: C1037-50.
6. 6 Punnonen K, Pustinen T, Jansen CT. Ultraviolet B irradiation induces changes in the distribution and release of arachidonic acid, dihomo-gamma-linolenic acid, and eicosapentanoic acid in human keratinocytes in culture. J Invest Dermatol 1987; 88: 611-14.
7. 7 Smith WL. Prostanoid biosynthesis and mechanisms of action. Am J Physiol 1992; 263: F181-91.
8. 8 Tsujii MS, Kawano S, Dubois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997; 94: 3336-40.
9. 9 Ristimäki AN, Honkanen H, Jänkälä P et al. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997; 57: 1276-80.
10. 10 Feng L, Xia Y, Garcia GE et al. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide, J Clin Invest 1995; 95: 1669-75.
11. 11 Leeong J. Hughes-Fulford M, Rakhlin N et al. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp Cell Res 1996; 224: 79-87.
12. 12 Snellman E, Jansen CT, Leszczynski K et al. Ultraviolet erythema sensitivity in anamnestic (I-IV) and phototested (1-4) caucasian skin phototypes: the need for a new classification system. Photochem Photobiol 1995; 62: 769-72.
13. 13 Diffey BL, Jansen CT, Urbach F et al. The standard erythema dose: a new photobiological concept. Photodermatol Photoimmunol Photomed 1997; 13: 64-6.
14. 14 Hidaka H, Inagaki M, Kawamoto S et al. Isoquinoline sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase C. Biochemistry 1984; 23: 5036-41.
15. 15 Maldve RE, Fischer SM. Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes. Mol Carcinog 1996: 17: 207-16.
16. 16 Hempel SL, Monick MM, Hunninghake GW. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invent 1994; 93: 391-6.
17. 17 Geng Y, Blanco FJ. Cornelisson M et al. Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes, J Immunol 1995; 155: 796-801.
18. 18 Hirai K, Takayama H, Tomo K et al. Protein-tyrosine-kinase-dependent expression of cyclooxygenase-1 and -2 mRNAs in human endothelial cells. Biochem J 1997; 322: 373-7.
19. 19 Tyrrell RM. Activation of mammalian gene expression by the UV component of sunlight - from models to reality. Bioessays 1996; 18: 139-48.
20. 20 Tyrrell RM. Oxidant, antioxidant status and photocarcinogenesis: the role of gene activation. Photochem Photobiol 1996; 63: 380-3.
21. 21 Garmyn M, Degreef H. Suppression of UVB-induced c-fos and c-jun expression in human keratinocytes by N-acetyleysteine, J Photochem Photobiol B 1997; 57: 125-30.
22. 22 De Vries N, De Flora S. N-Acetyl-L-cysteine. J Cell Biochem 1993: 17F: 270-7.
23. 23 Steenvoorden DPT, Beijersbergen van Henegouwen GMJ. Cysteine derivatives protect against UV-induced reactive intermediates in human keratinocytes: the role of glutathione synthesis. Photochem Photobiol 1997; 66: 665-71.
24. 24 Kang-Rotondo CH, Miller CC. Morrison AR et al. Enhanced keratinocyte prostaglandin synthesis after UV injury is due to increased phospholipase activity. Am J Physiol 1993; 264: C396-401.
25. 25 Snyder DS. Eaglstein WH. Topical indomethacin and sunburn. Br J Dermatol 1974; 90: 91-5.
26. 26 Farr PM, Diffey BL. A quantitative study of the effect of topical indomethacin on cutaneous erythema induced by UVB and UVC radiation, Br J Dermatol 1986; 115: 453-66.
27. 27 Ibbotson SH, Diffey BL, Farr PM. The effect of topical indomethacin on ultraviolet-radiation-induced erythema. Br J Dermatol 1996; 135: 523-7.
28. 28 DeWitt D, Smith WL. Yes, but do they still get headaches? Cell 1995; 83: 545-8.
29. 29 Tsujii M, Dubois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493-501.
30. 30 Williams CS, Smalley W, Dubois RN. Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invent 1997; 100: 1325-9.
31. 31 Thun MJ, Namhoodiri MM, Health CW. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 1593: 1593-6.
32. 32 Giovannuchi E. Egan KM, Hunter DJ et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995; 333: 609-14.
33. 33 Gridley G, McLaughlin JK, Ekbom A et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993; 85: 107-11.
34. 34 Sheng H, Shao J, Kirkland SC et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997; 99: 2254-9.
35. 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-9.